NCT00472563View on ClinicalTrials.gov

Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Acute Kidney Failure
Interventions
DRUG

Bicarbinate 150 mEq/L

75 cc of sodium bicarbonate (8.4%) mixed in 425 cc of D5W

Trial Locations (1)

57

Hospital Universitario San Vicente Paúl, Medellín

All Listed Sponsors
lead

Universidad de Antioquia

OTHER

NCT00472563 - Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate | Biotech Hunter | Biotech Hunter